名稱 | β-thalassemia mutation Reference Standard Ⅱ |
型號 | CBPD0002 |
報價 | ![]() |
特點(diǎn) | β-thalassemia mutation Reference Standard Ⅱ |
產(chǎn)品搜索
相關(guān)文章
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- 自身免疫疾病潛力靶點(diǎn)——IL-5藥篩細(xì)胞模型
- 抗衰老全新靶點(diǎn),抑制IL-11通路可延長哺乳動物壽命
- PDGFRA靶點(diǎn)藥物細(xì)胞篩選模型
- 腫瘤細(xì)胞調(diào)控關(guān)鍵因子和機(jī)制的研究講解
- 4-1BB(CD137)靶點(diǎn)藥物篩選模型
- 官宣!Ba/F3激酶穩(wěn)定細(xì)胞株&科佰激酶篩選平臺
- Cell Rep:發(fā)現(xiàn)治療乳腺癌轉(zhuǎn)移的重要新靶標(biāo)!
- 【新品上線】AXL篩選模型
- 基于納米顆粒的組合免疫療法對致命性癌癥發(fā)起三重打擊
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0002β-thalassemia mutation Reference Standard Ⅱ

- 詳細(xì)內(nèi)容
Introduction | |
Format | Genomic DNA |
Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
Technical Data | |
Variation site | IVS-I-110(G>A) |
DNA Change | c.93-21G>A |
Zygosity | Homozygous |
Allelic Frequency | 100% |
Transcript | NM_000518.5 |
Chr position(GRCh37) | Chr11:5248050C>T |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | Figure 1. IVS-I-110(G>A) Homozygous |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |